Home > Publications database > Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer > print

001     294403
005     20250210094928.0
024 7 _ |a 10.1021/acsmedchemlett.4c00324
|2 doi
037 _ _ |a DKFZ-2024-02232
082 _ _ |a 610
100 1 _ |a Liolios, Christos
|0 P:(DE-He78)c8c77862236d6e9b311705b9ecdf0413
|b 0
|e First author
245 _ _ |a Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
260 _ _ |a Washington, DC
|c 2024
|b ACS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1739177334_28365
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ACS Med. Chem. Lett. 2024, 15, 11, 1970–1978 / #EA:W630#
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Bouziotis, Danai
|b 1
700 1 _ |a Sihver, Wiebke
|0 0000-0002-2876-9925
|b 2
700 1 _ |a Schäfer, Martin
|0 P:(DE-He78)3373acf5d3b93adfd9ea973cf2d218aa
|b 3
|u dkfz
700 1 _ |a Lambrinidis, George
|0 0000-0002-2820-9338
|b 4
700 1 _ |a Salvanou, Evangelia-Alexandra
|b 5
700 1 _ |a Bauder-Wüst, Ulrike
|0 P:(DE-He78)033d979f00729281e709b85fe6cae972
|b 6
|u dkfz
700 1 _ |a Benesova, Martina
|0 P:(DE-He78)0f034e05cefb010f991ef8b96009d95c
|b 7
|u dkfz
700 1 _ |a Kopka, Klaus
|b 8
700 1 _ |a Kolocouris, Antonios
|0 0000-0001-6110-1903
|b 9
700 1 _ |a Bouziotis, Penelope
|0 0000-0001-6778-2201
|b 10
773 _ _ |a 10.1021/acsmedchemlett.4c00324
|g p. acsmedchemlett.4c00324
|0 PERI:(DE-600)2532386-6
|n 11
|p 1970–1978
|t ACS medicinal chemistry letters
|v 15
|y 2024
|x 1948-5875
909 C O |p VDB
|o oai:inrepo02.dkfz.de:294403
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)c8c77862236d6e9b311705b9ecdf0413
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)3373acf5d3b93adfd9ea973cf2d218aa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)033d979f00729281e709b85fe6cae972
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)0f034e05cefb010f991ef8b96009d95c
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACS MED CHEM LETT : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1200
|2 StatID
|b Chemical Reactions
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-26
920 1 _ |0 I:(DE-He78)W630-20160331
|k W630
|l Radiopharmazeutika und Präklinische Studien
|x 0
920 0 _ |0 I:(DE-He78)W630-20160331
|k W630
|l Radiopharmazeutika und Präklinische Studien
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)W630-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21